Biohaven Quick Ratio 2016-2023 | BHVN

Historical quick ratio values for Biohaven (BHVN) over the last 10 years.
Biohaven Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2023-03-31 $0.00B $0.11B 0.00
2022-12-31 $0.00B $0.09B 0.00
2022-09-30 $0.00B $0.03B 0.00
2022-06-30 $1.07B $0.67B 1.59
2022-03-31 $1.08B $0.58B 1.87
2021-12-31 $0.00B $0.04B 0.00
2021-09-30 $0.87B $0.46B 1.88
2021-06-30 $0.60B $0.40B 1.51
2021-03-31 $0.84B $0.40B 2.13
2020-12-31 $0.56B $0.28B 2.03
2020-09-30 $0.69B $0.22B 3.17
2020-06-30 $0.35B $0.17B 2.13
2020-03-31 $0.47B $0.12B 3.85
2019-12-31 $0.00B 0.00
2019-09-30 $0.00B $0.05B 0.00
2019-06-30 $0.00B $0.05B 0.00
2019-03-31 $0.00B $0.02B 0.00
2018-12-31 $0.00B $0.02B 0.00
2018-09-30 $0.00B $0.02B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.02B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.02B 0.00
2017-06-30 $0.00B $0.02B 0.00
2017-03-31 $0.00B $0.02B 0.00
2016-12-31 $0.00B $0.01B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.059B $0.463B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.076B 8.19
GSK (GSK) United Kingdom $70.106B 9.78
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.491B 22.15
Ginkgo Bioworks Holdings (DNA) United States $3.170B 0.00
Arcus Biosciences (RCUS) United States $1.611B 0.00
Emergent Biosolutions (EBS) United States $0.412B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.175B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00